TFF Pharmaceuticals Inc (NAS:TFFP)
$ 1.87 0 (0%) Market Cap: 6.48 Mil Enterprise Value: 2.17 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 29/100

TFF Pharmaceuticals Inc at SNN Network Summer Event (Virtual) Transcript

Aug 19, 2021 / 05:30PM GMT
Release Date Price: $200.25 (-6.75%)
Operator

Welcome to the SNN Network Summer Virtual Event. We are pleased to introduce the next presenter for today's event, Glenn Mattes, President, CEO, and Director of TFF Pharmaceuticals. Glenn, the floor is yours.

Glenn Mattes
TFF Pharmaceuticals, Inc. - President, CEO, & Director

Thank you, and welcome. My name is Glenn Mattes as I was introduced here. I've been the CEO at TFF for the last four years, and we're happy to present the story on TFF Pharmaceuticals to you. Hopefully, I'll be able to have some time left at the end to take some questions. Hopefully, you're having a good conference and a good day.

As a quick reminder that we are working under a Safe Harbor statement that you can review and read at your [pleasure]. So TFF Pharmaceuticals is a company that is founded around a platform technology called thin film freezing. This technology has the ability to create dry powder drugs that are transformed and formulated off of the other compounds that are mostly in a solid state, okay?

These drugs usually come to us in need of formulation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot